Complementary and alternative medicine for the allergist-immunologist

Where do I start?

Renata J M Engler, Catherine M. With, Philip J. Gregory, Jeff M. Jellin

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.

Original languageEnglish
JournalJournal of Allergy and Clinical Immunology
Volume123
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Complementary Therapies
Allergists
Referral and Consultation
Physicians
Safety
Information Management
Drug Evaluation
Information Dissemination
Allergy and Immunology
Drug-Related Side Effects and Adverse Reactions
Biological Products

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Complementary and alternative medicine for the allergist-immunologist : Where do I start? / Engler, Renata J M; With, Catherine M.; Gregory, Philip J.; Jellin, Jeff M.

In: Journal of Allergy and Clinical Immunology, Vol. 123, No. 2, 02.2009.

Research output: Contribution to journalArticle

Engler, Renata J M ; With, Catherine M. ; Gregory, Philip J. ; Jellin, Jeff M. / Complementary and alternative medicine for the allergist-immunologist : Where do I start?. In: Journal of Allergy and Clinical Immunology. 2009 ; Vol. 123, No. 2.
@article{fb3ee26920184d4782126878c2cc4fed,
title = "Complementary and alternative medicine for the allergist-immunologist: Where do I start?",
abstract = "Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40{\%} of their patients may be using and another 50{\%} may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7{\%}). More than 5{\%} of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.",
author = "Engler, {Renata J M} and With, {Catherine M.} and Gregory, {Philip J.} and Jellin, {Jeff M.}",
year = "2009",
month = "2",
doi = "10.1016/j.jaci.2009.01.001",
language = "English",
volume = "123",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Complementary and alternative medicine for the allergist-immunologist

T2 - Where do I start?

AU - Engler, Renata J M

AU - With, Catherine M.

AU - Gregory, Philip J.

AU - Jellin, Jeff M.

PY - 2009/2

Y1 - 2009/2

N2 - Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.

AB - Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research.

UR - http://www.scopus.com/inward/record.url?scp=59549101116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59549101116&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2009.01.001

DO - 10.1016/j.jaci.2009.01.001

M3 - Article

VL - 123

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -